comprehensive -WSS

comprehensive

author：hotspot 2025-08-27 16:48:06 - browse：84

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Lilly’s weekly insulin works as well as daily products, new studies show

Wikipedia

WSS

House GOP plan to stem drug shortages differs from Democrats’

Abbott's new stent may help patients with peripheral artery disease

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Obesity drug from Roche shows promise in early study

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Oak Street deal isn't the answer to health care's woes

explore

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

As H5N1 spreads in cows, experts warn against drinking raw milk

BioMarin wins approval for gene therapy to treat hemophilia A

Free medical tuition alone isn't enough to close gaps in primary care

Virginia high school admissions case could be legal follow

The United States must get value

Novavax promises a turnaround & Lilly roils the obesity market

Many immigrants are left out of maternal health programs

focus

Doctors increasingly discourage vaping amid mounting health concerns

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

STAT series 'Denied by AI' wins major journalism prizes

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Boston hospital trains restaurant workers on naloxone for overdoses

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

focus

Wikipedia

hotspot

explore